Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results from a study led by The Royal Marsden NHS Foundation Trust. These findings, from the largest ever trial of postoperative radiotherapy in prostate cancer, are being presented today (Friday 27 September) at the 2019 ESMO Annual Meeting in Barcelona, Spain.